Rubens Reimão

Rubens Reimão

Auto-generated profile, based on publicly available information

Rubens Reimão

Universidade de São Paulo

Research Focus & Metrics

Academic Career Length

48Years (1979-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 1994 in Immunology Letters
Verified
Journal Article
Closed access
MDM Desousa
M Desousa
RRR Reimao
R Reimao
RLR Lacerda
R Lacerda
PHP Hugo
P Hugo
SKS Kaufmann
S Kaufmann
GPGraça Porto
Graça Porto

10 April 2013 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Closed access
PDF file
CIClara Odilia Inocente
Clara Odilia Inocente
SLSophie Lavault
Sophie Lavault
MLMichel Lecendreux
Michel Lecendreux
Yves DauvilliersYves Dauvilliers
Yves Dauvilliers
RRRubens Reimao
Rubens Reimao
PFPatricia Franco
Patricia Franco

1 March 2012 in Clinical Neuropharmacology
Verified
Journal Article
Closed access
CIClara Inocente
Clara Inocente
IAIsabelle Arnulf
Isabelle Arnulf
HBHélène Bastuji
Hélène Bastuji
ATAnne Thibault-Stoll
Anne Thibault-Stoll
ARAude Raoux
Aude Raoux
PFPatricia Franco
Patricia Franco
Narcolepsy is a rare disabling sleep disorder characterized by excessive daytime sleepiness and cataplexy (sudden loss of muscle tone). Drugs such as pitolisant, which block histamine H3 autoreceptors, constitute a newly identified class of stimulants because they increase brain histamine and enhance wakefulness in animal and human adult narcolepsy. We report our experience with the off-label use of pitolisant in 4 teenagers with narcolepsy/cataplexy with severe daytime sleepiness, refractory to available treatments (modafinil, methylphenidate, mazindol, sodium oxybate, and D-amphetamine). All teenagers developed their disease during childhood (11.3 ± 2.4 years; 50% boys) and were 17.3 ± 0.8 years old at the time of pitolisant therapy. Pitolisant treatment was increased from 10 to 30 mg (n = 1) and 40 mg (n = 3). The adapted Epworth Sleepiness Score decreased from 14.3 ± 1.1 to 9.5 ± 2.9 (P = 0.03) with pitolisant alone to 7 ± 3.4 when combined with mazindol (n = 1), methylphenidate (n = 1), or sodium oxybate plus modafinil (n = 1). Mean sleep onset latency increased from 31 ± 14 minutes to 36 ± 8 minutes (P = 0.21) on the maintenance of wakefulness test. The severity and frequency of cataplexy were slightly improved. Adverse effects were minor (insomnia, headache, hot flushes, leg pain, and hallucinations) and transitory, except for insomnia, which persisted in 2 teenagers. The benefit was maintained after a mean of 13 months. Pitolisant could constitute an acceptable alternative for the treatment of refractory sleepiness in teenagers with narcolepsy.

1 March 2014 in Sleep Medicine
Verified
Journal Article
Closed access
CIClara Odilia Inocente
Clara Odilia Inocente
MGMarie-Paule Gustin
Marie-Paule Gustin
SLSophie Lavault
Sophie Lavault
AGAnne Guignard-Perret
Anne Guignard-Perret
ARAude Raoux
Aude Raoux
PFPatricia Franco
Patricia Franco

12 June 2014 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Closed access
PDF file
CIClara O. Inocente
Clara O. Inocente
MGMarie‐Paule Gustin
Marie‐Paule Gustin
SLSophie Lavault
Sophie Lavault
AGAnne Guignard‐Perret
Anne Guignard‐Perret
ARAude Raoux
Aude Raoux
PFPatricia Franco
Patricia Franco

1 December 2005 in Arquivos de Neuro-Psiquiatria
Verified
Journal Article
Open access
PDF file
JSJosé Carlos Souza
José Carlos Souza
Teresa R. PaivaTeresa R. Paiva
Teresa R. Paiva
RRRubens Reimão
Rubens Reimão
OBJECTIVE: To evaluate the quality of sleep, shift work, alcohol and psychostimulant drug use, and the prevalence of accidents among truck drivers. METHOD: Data were collected using a demographic questionnaire, the Epworth Sleepiness Scale (ESS) and the Pittsburgh sleep quality index (PSQI). Statistical analysis was conducted using the Student t, chi-square, Pearson and Fisher tests. RESULTS: 43.2% of the drivers drove over 16 h a day, and 2.9% worked shifts. Mean number of sleep hours/day was 5.97±1.47; 23.8% slept 5; 23 subjects snored more than three times a week (11.1%). Mean ESS was 6.56±4.2; 21.7% had a score >10. In the preceding five years, 27 drivers (13.1%) were involved in accidents, 5 of which resulted in injuries and 3 in deaths. CONCLUSION: Results showed a high prevalence of sleep disorders, use of alcohol and psychostimulant drugs, and accidents.